FDA Gives Fast Track Status to Vaccinex Drug

Rochester Business Journal
August 8, 2016

The Food and Drug Administration has given Vaccinex Inc.’s VX15 Huntington’s disease drug fast track status.

Huntington’s disease is a relatively rare affliction, affecting an estimated one in 10,000 individuals. Still, for sufferers and their families it amounts to a drawn out and increasingly unpleasant death sentence.

Read full article